- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Certolizumab pegol – March 2014
Certolizumab Pegol, 200 mg/mL injection, 2 x 1 mL syringes, Cimzia®
Last updated
8 November 2023
